# Why this mRNA cancer vaccine is raising new treatment hope

https://mins.news/en/video/26783

- Reuters, 2026-08-20 00:15 UTC
- Health
- Original: https://www.youtube.com/watch?v=qlbNSdHAXUc

> Moderna and Merck said a personalized mRNA cancer vaccine cut the risk of melanoma returning and spreading in a late-stage trial, sending Moderna shares up as much as 160%.

## Related coverage

- [Moderna, Merck say mRNA treatment cuts melanoma recurrence, spread risk](https://mins.news/en/video/27354) — CNA, 2026-08-20
- [Moderna shares surge after experimental mRNA cancer treatment passes key test](https://mins.news/en/item/26647) — The Associated Press, 2026-08-19
- [Moderna and Merck unveil mRNA cancer vaccine that cuts melanoma spread](https://mins.news/en/item/26640) — Al Jazeera, 2026-08-19
- [Personalized mRNA cancer vaccine shows promise](https://mins.news/en/video/26585) — ABC News, 2026-08-19
- [Moderna and Merck Revive mRNA Hopes With Melanoma Trial Success](https://mins.news/en/item/26437) — Bloomberg News, 2026-08-19
- [Moderna-Merck combination succeeds in late-stage skin cancer trial](https://mins.news/en/item/26142) — CNN, 2026-08-19